City
Epaper

Prioritisation has to be done on criteria for COVID-19 vaccination, says Dr VK Paul

By ANI | Published: October 27, 2020 9:28 PM

Amid claims of various state governments that it would provide free Covid-19 vaccinations, the Union government's expert group on vaccines on Tuesday said that they should wait for a clearer picture to emerge on vaccine prioritisation.

Open in App

Amid claims of various state governments that it would provide free Covid-19 vaccinations, the Union government's expert group on vaccines on Tuesday said that they should wait for a clearer picture to emerge on vaccine prioritisation.

"We've requested state governments to wait for an overall picture to become clear ad to take a national approach towards engaging compes, and deciding the criteria for the vaccine. Prioritisation has to be done," Dr VK Paul, Member (Health), NITI Aayog and chairperson of Covid-19 taskforce committee said on Tuesday while addressing a Union Health Ministry's press conference.

He also said that at present there is no vaccine in the world and that it is fortunate that trials are being done on Indian soil.

"We are working to look at our approach to vaccine implementation. As and when vaccines are available, and in that regard, the access to vaccines will be in such a way that vaccine supply is not unlimited. Prioritisation has to be done. The prioritisation principles will be determined on the basis of availability of the vaccine, who should be getting that vaccine," he stated.

Dr Paul added that discussions in the committee of Union Government are being conducted and blueprints are being finalized and added that committee and oversee that in order to deliver the vaccine to priority groups, there will be no problems in terms of resources.

Dr Balram Bhargava, Director General (DG ) of the Indian Council of Medical Research (ICMR) who was also present in the media meet informed that currently, three vaccines are in different stages of trial in India.

"There are three vaccine candidates in different stages of clinical testing- Covaxin has got approval for phase III trials, Cadila also progressing with phase-II trials & Serum is completing phase 2b trial and has an ongoing trial in Brazil, South Africa, and the US," said Dr Bhargava.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Union Health MinistryUnion GovernmentBalram Bhargava
Open in App

Related Stories

NationalGovernment Lifts Onion Export Ban, Sets Minimum Export Price at USD 550 Per Tonne

NationalCEC Rajiv Kumar's Security Increased Due to International Threats: ECI Sources

NationalGovernment Cancels FCRA Registration of Centre for Policy Research for Alleged Law Violations

HealthDoctors who scored zero can now study PG medical courses

MaharashtraSharad Pawar slams BJP-led Union govt over Manipur violence, misuse of probe agencies

National Realted Stories

NationalLalu Prasad bats for Muslim reservation, Samrat Choudhary hits back

NationalTwo terrorists killed in gunfight with security forces in J&K’s Kulgam

NationalDelhi Police launches WhatsApp channel for city residents

NationalRajasthan reels under heatwave, Barmer sizzles at 42.9-degree Celsius

NationalChikkodi leads as polling picks up pace in Karnataka's 14 LS seats